مرکز منطقه ای اطلاع رساني علوم و فناوري - Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)

Title of article :

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)

Author/Authors :

Christoph Kaiser، نويسنده , , Hans Peter Brunner-La Rocca، نويسنده , , Peter T Buser، نويسنده , , Piero O. Bonetti، نويسنده , , Stefan Osswald، نويسنده , , Andre Linka، نويسنده , , Alain Bernheim، نويسنده , , Andreas Zutter، نويسنده , , Michael Zellweger، نويسنده , , Leticia Grize، نويسنده , , Matthias E. Pfisterer، نويسنده ,

Issue Information :

روزنامه با شماره پیاپی سال 2006

Pages :

From page :

921

To page :

929

Abstract :

Background No prospective trial-based data are available for incremental cost-effectiveness of drug-eluting stents (DES) compared with bare-metal stents (BMS) in unselected patients, as treated in everyday practice. Methods The Basel stent cost-effective

Journal title :

The Lancet

Serial Year :

2006

Journal title :

The Lancet

Record number :

588646

Link To Document :

https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=588646